BARA NAJI HAMDI ALZGHOUL
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology MOREHEAD, KY NPI 1205231925
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology KY NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$1,591.92
- Category: General Payments
- Program years: PY2018–2024
- Record count: 51
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,007.24 across 45 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $838.74 | 42 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $125.00 | 1 |
| Education | $43.50 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $133.89 | 6 |
| Acrotech Biopharma Inc. | $125.00 | 1 |
| Merck Sharp & Dohme Corporation | $105.25 | 5 |
| TAIHO ONCOLOGY, INC. | $51.24 | 2 |
| PFIZER INC. | $48.22 | 3 |
| Acerta Pharma LLC | $45.06 | 2 |
| Astellas Pharma US Inc | $43.74 | 2 |
| Kyowa Kirin, Inc. | $40.55 | 2 |
| Ipsen Biopharmaceuticals, Inc | $38.70 | 2 |
| AVEO Pharmaceuticals, Inc. | $37.88 | 2 |
| ABBVIE INC. | $37.08 | 2 |
| E.R. Squibb & Sons, L.L.C. | $31.50 | 2 |
| Celgene Corporation | $31.01 | 2 |
| Tempus AI, Inc | $28.09 | 1 |
| Regeneron Healthcare Solutions, Inc. | $27.48 | 1 |
| ARGENX US, INC. | $21.22 | 1 |
| Janssen Biotech, Inc. | $21.15 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.99 | 1 |
| Daiichi Sankyo Inc. | $19.77 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.75 | 1 |
| GENZYME CORPORATION | $18.02 | 1 |
| Genmab U.S., Inc. | $17.53 | 1 |
| EISAI INC. | $17.08 | 1 |
| Genentech USA, Inc. | $15.16 | 1 |
| ARRAY BIOPHARMA INC | $13.88 | 1 |
By program year
Records — PY2024 (45)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.